This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and ...
Regeneron secures a temporary restraining order against Mylan and Biocan, preventing them from launching a generic version of ...
The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other ...